secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonnet BioTherapeutics Holdings, Inc. (—)
CIK:        0001106838
Form:       8-K
Filed at:   2025-07-02T23:59:59+00:00
Accession:  0001641172-25-017478
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonnet BioTherapeutics raises $2.0M via zero-interest convertible notes and warrants; conversion at $1.156/share
--------------------------------------------------------------------------------

- Completed sale of $2.0M aggregate principal convertible notes to accredited investors, plus ~$50,000 from warrants.
- Convertible notes bear no interest, mature June 30, 2026; convertible into up to 1,730,104 shares at $1.156 per share.
- Warrants to purchase 865,052 shares at $1.156 per share, exercisable for five years.
- If no subsequent offering of $5M+ within 90 days, investors can buy additional warrants and company must file registration statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1106838/000164117225017478/0001641172-25-017478-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1106838/000164117225017478/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-017478

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer